Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Azitra Logo
Azitra Growth Score
66
CB Rank
5838
Heat Score
70
Azitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases.
Founded
obfuscation
PublicPost-IPO Equity Branford, Connecticut, United States11-50 www.azitrainc.com/
Alternative Medicine
Biotechnology
Consumer Goods
Health Care
Overview

Azitra
Total Funding
obfuscation
Growth Score
66
Heat Score
70

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score66
-1 pts
in past quarter
Heat Score 70
1 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
+2 more milestones
See more interactive data and historical milestones on desktop for the best experience

About Azitra

CB Rank
5838
Azitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases.
Founded
obfuscation
PublicPost-IPO Equity Branford, Connecticut, United States11-50 www.azitrainc.com/
Alternative Medicine
Biotechnology
Consumer Goods
Health Care

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name Azitra Inc.
Operating Status Active
Stock Symbol  NYSEMKT:AZTR
Company Type For Profit
Founders  Azim Munivar, Travis Whitfill
About the Company

Azitra is a clinical-stage medical dermatology company that leverages extensive scientific knowledge about the skin microbiome to discover and develop novel products for the treatment of adverse skin conditions and diseases.The Company’s technology platform, developed in collaboration with scientists at Yale University and the Jackson Laboratory,

is based on a proprietary strain of the natural commensal bacteria Staphylococcus epidermidis.

Phone Number (203)599-0700
Contact Email info@azitrainc.com
Predictions & Insights

Growth Insight

See this Growth Insight
Azitra is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

ATR-12
A genetically engineered S. epidermidis strain that secretes LEKTI protein, developed to treat Netherton syndrome by addressing skin barrier defects.
ATR-04
An auxotrophic S. epidermidis strain engineered to treat rash associated with EGFR inhibitor cancer therapies by modulating skin microbiome and immune responses.

Research & Development

Azitra is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 16
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Azitra Logo
Post-IPO Equity - Azitra
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Azitra Logo
Post-IPO Equity - Azitra
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Azitra Logo
Post-IPO Equity - Azitra
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Azitra Logo
Post-IPO Equity - Azitra
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Azitra Logo
Post-IPO Equity - Azitra
2
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 16
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Azitra Logo
Post-IPO Equity - Azitra
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Azitra Logo
Post-IPO Equity - Azitra
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Azitra Logo
Post-IPO Equity - Azitra
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Azitra Logo
Post-IPO Equity - Azitra
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Azitra Logo
Post-IPO Equity - Azitra
2
obfuscation
— Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Nantahala Capital Management Logo
Nantahala Capital Management
—
Post-IPO Equity - Azitra Logo
Post-IPO Equity - Azitra
—
Nantahala Capital Management Logo
Nantahala Capital Management
—
Post-IPO Equity - Azitra Logo
Post-IPO Equity - Azitra
—
Nantahala Capital Management Logo
Nantahala Capital Management
—
Post-IPO Equity - Azitra Logo
Post-IPO Equity - Azitra
—
Nantahala Capital Management Logo
Nantahala Capital Management
—
Post-IPO Equity - Azitra Logo
Post-IPO Equity - Azitra
—
Nantahala Capital Management Logo
Nantahala Capital Management
—
Post-IPO Equity - Azitra Logo
Post-IPO Equity - Azitra
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 3 Board Members and Advisors 2 Contacts 10

Employee Profiles

Board Members and Advisors

News

News and Press

News•May 19, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 13, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 13, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 6, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

2,081
99.33%
 in past month

IT Spend

$174This year, Azitra is projected to spend $174 on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Meta Platforms, Inc. Logo
Meta Platforms, Inc.
88
VivaTech Logo
VivaTech
86
Zoom Logo
Zoom
79

Actively Used Products

9Azitra uses 9 technology products and services including HTML5, Google Analytics, and  F5 NGINX, according to G2 Stack.

Active Website Tech Count

19Azitra is actively using 19 technologies for its website, according to BuiltWith. These include HSTS, jsDelivr, and  jQuery CDN.
Sub-Organizations
Frequently Asked Questions

Where is Azitra's headquarters? Azitra is located in Branford, Connecticut, United States.Who invested in Azitra? Azitra has 14 investors including Nantahala Capital Management and  Stonepine Capital Management.When was the last funding round for Azitra? Azitra closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Azitra's competitors? Alternatives and possible competitors to Azitra may include Apogee Therapeutics, Triveni Bio, and  Aclaris Therapeutics.How much funding has Azitra raised to date? Azitra has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|